Methemoglobinemia: Difference between revisions
From IDWiki
(Imported from text file) |
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
||
Line 16: | Line 16: | ||
* Ingestion of nitrate compounds, e.g. bismuth nitrate |
* Ingestion of nitrate compounds, e.g. bismuth nitrate |
||
== Clinical |
== Clinical Manifestations == |
||
* Cyanosis and symptoms of hypoxia |
* Cyanosis and symptoms of hypoxia |
Latest revision as of 14:55, 15 July 2020
Differential Diagnosis
- Antibiotics
- Dapsone (most common)
- Trimethoprim
- Sulfonamides
- Local anesthetics
- Articaine
- Benzocaine
- Prilocaine
- Aniline dyes
- Metoclopramide
- Rasburicase
- Chlorates
- Bromates
- Ingestion of nitrate compounds, e.g. bismuth nitrate
Clinical Manifestations
- Cyanosis and symptoms of hypoxia
- Hypoxia that does not respond to supplemental oxygen
- Clinical cyanosis in the presence of a normal arterial pO2
Management
- Stop offending agent
- If otherwise well and metHb level < 20%, can monitor
- If unwell or metHb > 30%
- Methylene blue 1-2 mg/kg over 2-5 minutes
- Repeat dose in an hour if metHb still high (e.g. >20%)
- Contraindicated in G6PD deficiency
- May cause serotonin syndrome
- Second-line
- Ascorbic acid
- Exchange transfusion
- Methylene blue 1-2 mg/kg over 2-5 minutes